(IFF) International Flavors - Ratings and Ratios
Flavors, Fragrances, Food Ingredients, Pharma Excipients, Specialty Chemicals
IFF EPS (Earnings per Share)
IFF Revenue
Description: IFF International Flavors
International Flavors & Fragrances Inc. (NYSE:IFF) is a global leader in the production and marketing of various products, including food, beverages, health and biosciences, scent, and pharma solutions. The company operates through four main segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions, catering to diverse industries such as food, beverages, pharmaceuticals, and personal care.
The Nourish segment is a key contributor, offering a range of natural-based ingredients, including plant-based specialty food ingredients, emulsifiers, and sweeteners. IFFs product portfolio also includes flavor compounds, savory solutions, and ingredients for beverages, sweets, and dairy products. With a strong presence in the global food and beverage industry, the company is well-positioned to capitalize on trends such as clean labeling, sustainability, and health-oriented consumer preferences.
From a financial perspective, IFFs market capitalization stands at approximately $18.98 billion, with a forward price-to-earnings ratio of 17.89. While the companys return on equity (RoE) is currently negative at -5.96%, this metric may be influenced by various factors such as restructuring costs, acquisition-related expenses, or industry headwinds. To gauge the companys profitability, we can examine other key performance indicators (KPIs) such as gross margin, operating margin, and EBITDA margin.
Some key KPIs to monitor for IFF include revenue growth, segment-wise profitability, and cash flow generation. The companys ability to maintain its pricing power, manage raw material costs, and invest in research and development (R&D) will be crucial in driving long-term growth. Additionally, IFFs exposure to various end-markets and geographies can help mitigate risks associated with specific industries or regions.
To further analyze IFFs stock, we can examine its technical indicators, such as relative strength index (RSI), Bollinger Bands, or moving average convergence divergence (MACD). These tools can help identify trends, patterns, and potential trading opportunities. However, it is essential to combine technical analysis with fundamental insights to form a comprehensive view of the companys prospects.
IFF Stock Overview
| Market Cap in USD | 16,869m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception | 1981-12-31 |
IFF Stock Ratings
| Growth Rating | -65.6% |
| Fundamental | 40.8% |
| Dividend Rating | 19.7% |
| Return 12m vs S&P 500 | -42.9% |
| Analyst Rating | 4.14 of 5 |
IFF Dividends
| Dividend Yield 12m | 2.71% |
| Yield on Cost 5y | 1.85% |
| Annual Growth 5y | -12.05% |
| Payout Consistency | 97.4% |
| Payout Ratio | 40.6% |
IFF Growth Ratios
| Growth Correlation 3m | -73.7% |
| Growth Correlation 12m | -93.9% |
| Growth Correlation 5y | -71.9% |
| CAGR 5y | -9.04% |
| CAGR/Max DD 5y | -0.16 |
| Sharpe Ratio 12m | -0.86 |
| Alpha | -43.31 |
| Beta | 0.495 |
| Volatility | 26.87% |
| Current Volume | 1521.8k |
| Average Volume 20d | 2018.9k |
| Stop Loss | 65.4 (-3.1%) |
| Signal | 0.65 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (-393.0m TTM) > 0 and > 6% of Revenue (6% = 678.2m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -2.42pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 23.93% (prev 41.76%; Δ -17.83pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 889.0m > Net Income -393.0m (YES >=105%, WARN >=100%) |
| Net Debt (6.03b) to EBITDA (808.0m) ratio: 7.47 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.85 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (257.0m) change vs 12m ago 0.39% (target <= -2.0% for YES) |
| Gross Margin 36.25% (prev 31.43%; Δ 4.82pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 40.61% (prev 38.29%; Δ 2.32pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.75 (EBITDA TTM 808.0m / Interest Expense TTM 275.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.18
| (A) 0.10 = (Total Current Assets 5.89b - Total Current Liabilities 3.18b) / Total Assets 26.12b |
| (B) -0.12 = Retained Earnings (Balance) -3.21b / Total Assets 26.12b |
| (C) -0.01 = EBIT TTM -205.0m / Avg Total Assets 27.83b |
| (D) -0.39 = Book Value of Equity -4.59b / Total Liabilities 11.69b |
| Total Rating: -0.18 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 40.80
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 1.07% = 0.54 |
| 3. FCF Margin 2.12% = 0.53 |
| 4. Debt/Equity 0.44 = 2.41 |
| 5. Debt/Ebitda 7.77 = -2.50 |
| 6. ROIC - WACC -6.86% = -8.58 |
| 7. RoE -2.80% = -0.47 |
| 8. Rev. Trend -55.70% = -2.79 |
| 9. Rev. CAGR -3.67% = -0.61 |
| 10. EPS Trend 30.44% = 0.76 |
| 11. EPS CAGR 34.87% = 2.50 |
What is the price of IFF shares?
Over the past week, the price has changed by -0.69%, over one month by -9.73%, over three months by -10.78% and over the past year by -33.15%.
Is International Flavors a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IFF is around 56.51 USD . This means that IFF is currently overvalued and has a potential downside of -16.29%.
Is IFF a buy, sell or hold?
- Strong Buy: 10
- Buy: 7
- Hold: 4
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the IFF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 84.3 | 24.8% |
| Analysts Target Price | 91.9 | 36.1% |
| ValueRay Target Price | 61.6 | -8.8% |
Last update: 2025-08-19 02:48
IFF Fundamental Data Overview
CCE Cash And Equivalents = 816.0m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 15.5763
P/S = 1.4924
P/B = 1.1711
P/EG = 0.8154
Beta = 1.055
Revenue TTM = 11.30b USD
EBIT TTM = -205.0m USD
EBITDA TTM = 808.0m USD
Long Term Debt = 5.68b USD (from longTermDebt, last quarter)
Short Term Debt = 595.0m USD (from shortTermDebt, last quarter)
Debt = 6.28b USD (Calculated: Short Term 595.0m + Long Term 5.68b)
Net Debt = 6.03b USD (from netDebt column, last quarter)
Enterprise Value = 22.33b USD (16.87b + Debt 6.28b - CCE 816.0m)
Interest Coverage Ratio = -0.75 (Ebit TTM -205.0m / Interest Expense TTM 275.0m)
FCF Yield = 1.07% (FCF TTM 240.0m / Enterprise Value 22.33b)
FCF Margin = 2.12% (FCF TTM 240.0m / Revenue TTM 11.30b)
Net Margin = -3.48% (Net Income TTM -393.0m / Revenue TTM 11.30b)
Gross Margin = 36.25% ((Revenue TTM 11.30b - Cost of Revenue TTM 7.21b) / Revenue TTM)
Tobins Q-Ratio = -4.86 (set to none) (Enterprise Value 22.33b / Book Value Of Equity -4.59b)
Interest Expense / Debt = 0.97% (Interest Expense 61.0m / Debt 6.28b)
Taxrate = 11.15% (from yearly Income Tax Expense: 31.0m / 278.0m)
NOPAT = -205.0m (EBIT -205.0m, no tax applied on loss)
Current Ratio = 1.85 (Total Current Assets 5.89b / Total Current Liabilities 3.18b)
Debt / Equity = 0.44 (Debt 6.28b / last Quarter total Stockholder Equity 14.40b)
Debt / EBITDA = 7.77 (Net Debt 6.03b / EBITDA 808.0m)
Debt / FCF = 26.16 (Debt 6.28b / FCF TTM 240.0m)
Total Stockholder Equity = 14.06b (last 4 quarters mean)
RoA = -1.50% (Net Income -393.0m, Total Assets 26.12b )
RoE = -2.80% (Net Income TTM -393.0m / Total Stockholder Equity 14.06b)
RoCE = -1.04% (Ebit -205.0m / (Equity 14.06b + L.T.Debt 5.68b))
RoIC = -0.91% (NOPAT -205.0m / Invested Capital 22.45b)
WACC = 5.95% (E(16.87b)/V(23.15b) * Re(7.84%)) + (D(6.28b)/V(23.15b) * Rd(0.97%) * (1-Tc(0.11)))
Shares Correlation 5-Years: 89.40 | Cagr: 0.20%
Discount Rate = 7.84% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈538.8m ; Y1≈353.7m ; Y5≈161.8m
Fair Price DCF = 12.41 (DCF Value 3.18b / Shares Outstanding 256.3m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: -55.70 | Revenue CAGR: -3.67%
Rev Growth-of-Growth: 3.24
EPS Correlation: 30.44 | EPS CAGR: 34.87%
EPS Growth-of-Growth: -33.12
Additional Sources for IFF Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle